# Glulisine + Lantus in Type I Patients

> **NCT00546702** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 142 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insuline Glulisine

## Key facts

- **NCT ID:** NCT00546702
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2005-02
- **Final completion:** 2005-02
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2009-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00546702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00546702, "Glulisine + Lantus in Type I Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00546702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*